Early study of a new device for treating a brain aneurysm
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a device called the FRED X to treat a single brain aneurysm that hasn't been treated before. It aims to see if the device is safe and works well for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one brain aneurysm that has not been treated yet.
- Your aneurysm is suitable for a catheter-based procedure (endovascular treatment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called the TUBE Device to treat unruptured brain aneurysms that are wide-necked or have a shape that makes them harder to treat. The device is placed inside the blood vessel to block blood flow to the aneurysm and reduce the risk of rupture.
This trial is gathering information from patients who are getting a standard treatment for a brain aneurysm using MicroVention devices. It helps doctors understand how well these treatments work in real life.
This trial tests a new device to block blood flow into unruptured brain aneurysms (balloon-like bulges). It is for adults whose aneurysm has not bled and fits specific size requirements. The goal is to see if the device is safe and works well.
This trial looks back at data from people in China who were treated with a device called FRED for brain aneurysms. It aims to understand how well the device works and how safe it is.
This trial tests a new device called the World Diverter Embolization Device to treat brain aneurysms (a weak spot in a blood vessel that can bulge or burst). The device is placed inside the artery to block blood flow into the aneurysm. This study checks if the device is safe and works well.
This trial tests a special metal mesh tube, called a flow diverter, to treat unruptured brain aneurysms. The goal is to see how safe and effective it is for preventing strokes.
Hear when a new Aneurysm Cerebral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.